Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic...
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products, today announces that...
Phase IIB study with KUR-111 meets primary efficacy endpoint Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and...
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products, today announces that it...
First Partnering Deal Based on Kuros' Synthetic Matrix Technologies Kuros Biosurgery AG, a biotechnology company focused on the development of novel...
- European Study is First Clinical Assessment of Kuros' Proprietary Synthetic Technology Kuros Biosurgery AG, a biotechnology company focused on the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.